ribociclib
novartis
['bcsm', 'ribociclib']
up now: presenting data on maintain: progression on et + any cdk 4/6 inhibitor --&gt; switching et + placebo versus switching et+ ribociclib. #bcsm #asco22
Breast & gyn med onc @valleyhospital in NJ. Focus on survivorship and ?????? onc. All opinions my own. Retweets not endorsements. Host of INTERLUDE podcast ??